Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 110 results.

Thumbnail for Temporal Trends and Demographic Disparities in Non-ALL Lymphoid Leukemia Mortality in the United States, 1999-2025: A CDC WONDER Analysis

CLL - 1241

Temporal Trends and Demographic Disparities in Non-ALL Lymphoid Leukemia Mortality in the United States, 1999-2025: A CDC WONDER Analysis

Pari Kotak

Poster Presenter: Pari Kotak

Thumbnail for Evolution of Infection-Associated Mortality Among Decedents With Chronic Lymphocytic Leukemia: A 22-Year National Multiple-Cause-of-Death Analysis, 2003-2024

CLL - 1256

Evolution of Infection-Associated Mortality Among Decedents With Chronic Lymphocytic Leukemia: A 22-Year National Multiple-Cause-of-Death Analysis, 2003-2024

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)

CLL - 1265

Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)

Nitin Jain

Poster Presenter: Nitin Jain

Thumbnail for Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

CLL - 1272

Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

Rishi Nanda

Poster Presenter: Rishi Nanda

Thumbnail for Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

CLL - 1278

Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

Aima Azhar

Poster Presenter: Aima Azhar

Thumbnail for Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

CLL - 1282

Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

Rishi Nanda

Poster Presenter: Rishi Nanda

Thumbnail for Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

CLL - 1285

Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

Xiaoyi Zhang

Poster Presenter: Xiaoyi Zhang

Thumbnail for Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

CLL - 1304

Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

Muhammad Usman Haider

Poster Presenter: Muhammad Usman Haider

Thumbnail for Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

CLL - 1309

Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

Jude Ossai

Poster Presenter: Jude Ossai

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.